Juma Bridgewater PhD

Juma Bridgewater is a Scientist III in the Analytical and Pharmaceutical Sciences group at ImmunoGen, Inc. He supports all aspects of antibody-drug conjugate (ADC) development at ImmunoGen, Inc. This includes the development, characterization and manufacture of antibody and cytotoxic intermediates, ADC drug substance and drug product. Juma specializes in the control of the manufacture of cytotoxic compounds, the characterization of drug intermediates, development of specifications and control of impurities in ADC drug substance. He has experience in small molecule compounds and ADCs in development and the preformulation of new chemical and biological entities in early development. Juma has extensive experience in the development and transfer of HPLC and GC assays as well as the development of novel HPLC-MS and oxidation chemistry based assays for characterization of proteins and small molecules. Juma worked at Vertex Pharmaceuticals and Abbott Laboratories (now AbbVie) prior to joining ImmunoGen, Inc. Juma received his PhD from the University of Massachusetts-Amherst and MS and BS degrees from the University of the West Indies, St. Augustine, Trinidad.